cyproteronacetaat 50 pch, tabletten 50 mg
pharmachemie b.v. swensweg 5 2031 ga haarlem - cyproteronacetaat 50 mg/stuk - tablet - crospovidon (e 1202) ; hyprolose (e 463) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat ; potato starch (ri) ; siliciumdioxide (e 551) ; talk (e 553 b), crospovidon (e 1202) ; hyprolose (e 463) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; potato starch (ri) ; siliciumdioxide (e 551) ; talk (e 553 b), - cyproterone
cyproteronacetaat/ethinylestradiol mylan 2 mg/0,035 mg, omhulde tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - cyproteronacetaat 2 mg/stuk ; ethinylestradiol 0,035 mg/stuk - omhulde tablet - calciumcarbonaat (e 170) ; glycerol 85 per cent (e 422) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; montaanglycolwas (e 912) ; polyethyleenglycol (e 1521) ; povidon (e 1201) ; saccharose ; talk (e 553 b) ; titaandioxide (e 171), - cyproterone and estrogen
cyproteronacetaat/ethinylestradiol teva 2/0,035 mg, omhulde tabletten
teva nederland b.v. swensweg 5 2031 ga haarlem - cyproteronacetaat ; ethinylestradiol - omhulde tablet - calciumcarbonaat (e 170) ; glycerol 85 per cent (e 422) ; lactose 1-water ; macrogol 6000 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; montaanglycolwas (e 912) ; povidon k 25 (e 1201) ; povidon k 90 (e 1201) ; saccharose ; talk (e 553 b) ; titaandioxide (e 171), - cyproterone and estrogen
sapropterine aurobindo 100 mg, oplosbare tabletten
sapropterinedihydrochloride 100 mg/stuk samenstelling overeenkomend met ; sapropterine 76,8 mg/stuk - oplosbare tablet - ascorbinezuur (l-) (e 300) ; calciumwaterstoffosfaat 0-water (e 341) ; crospovidon (e 1202) ; mannitol (d-) (e 421) ; natriumstearylfumaraat ; riboflavine (e 101), ascorbinezuur (l-) (e 300) ; calciumwaterstoffosfaat 0-water (e 341) ; crospovidon (e 1202) ; mannitol (d-) (e 421) ; natriumstearylfumaraat ; riboflavine
sapropterine teva 100 mg, oplosbare tabletten
sapropterinedihydrochloride 100 mg/stuk samenstelling overeenkomend met ; sapropterine 76,8 mg/stuk - oplosbare tablet - ascorbinezuur (l-) (e 300) ; crospovidon (e 1202) ; mannitol (d-) (e 421) ; maÏszetmeel, gepregelatineerd ; natriumstearylfumaraat ; riboflavine (e 101), ascorbinezuur (l-) (e 300) ; crospovidon (e 1202) ; mannitol (d-) (e 421) ; maÏszetmeel, gepregelatineerd ; natriumstearylfumaraat ; riboflavine
ethinylestradiol 0,035 mg /cyproteronacetaat 2 mg, omhulde tabletten
stragen nordic a/s helsingørsgade 8c dk-3400 hillerØd (denemarken) - cyproteronacetaat 2 mg/stuk ; ethinylestradiol 0,035 mg/stuk - omhulde tablet - calciumcarbonaat (e 170) ; glycerol 85 per cent (e 422) ; lactose 1-water ; macrogol 6000 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; montaanglycolwas (e 912) ; povidon k 25 (e 1201) ; povidon k 90 (e 1201) ; saccharose ; talk (e 553 b) ; titaandioxide (e 171), - cyproterone and estrogen
sapropterine dz 100 mg oplosbare tabletten
sapropterinedihydrochloride 100 mg/stuk samenstelling overeenkomend met ; sapropterine 76,8 mg/stuk - oplosbare tablet - ascorbinezuur (l-) (e 300) ; crospovidon (e 1202) ; mannitol (d-) (e 421) ; maÏszetmeel, gepregelatineerd ; natriumstearylfumaraat ; riboflavine (e 101), ascorbinezuur (l-) (e 300) ; crospovidon (e 1202) ; mannitol (d-) (e 421) ; maÏszetmeel, gepregelatineerd ; natriumstearylfumaraat ; riboflavine
abiraterone accord
accord healthcare s.l.u. - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
daphne continu 2 mg - 0,035 mg tabl.
ceres pharma sa-nv - cyproteronacetaat 2 mg (gele tablet); ethinylestradiol 35 µg (gele tablet); placebo (witte tablet) - tablet - 2 mg - 0,035 mg - cyproteronacetaat 2 mg; ethinylestradiol 35 µg; placebo - cyproterone and estrogen